What are the risks and recovery expectations?

Risks include infusion-related reactions (e.g., fever, chills, or headache), which are typically mild and managed with premedication. Rarely, infection, allergic reaction, or transient worsening of lupus symptoms may occur. Long-term risks are still under study, but no significant adverse events have been reported in short-term follow-ups. Recovery is ongoing, with most patients resuming normal activities immediately after each infusion. Clinical improvement in symptoms like fatigue, joint pain, and skin lesions may take weeks to months, and multiple cycles are sometimes needed for sustained benefit.